The study took place at sites in the UK, Australia, New Zealand and the European Union. Results showed that the combination of CST-103/CST-107 was both safe and well-tolerated, and importantly, that ...
Cell Signaling Technology, Inc. (CST) has announced an agreement with Novartis under which a pilot study was performed using CST's PhosphoScan™ technology to identify phosphorylation sites and ...
Analysis results highlight the efficacy of cough suppression therapy (CST) for those with chronic refractory cough and voice disorders. Results of a retrospective analysis show cough suppression ...
The CST study was supposed to be conducted with BeiGene Ltd (NASDAQ: BGNE), which licensed the rights to VBR in China. The company will prioritize its portfolio of next-generation core inhibitors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback